Dr. Samuel Achilefu's lab focuses on creating advanced nanomedicine techniques to help treat cancer and bone diseases. By developing tiny particles that can deliver therapy precisely to tumors without needing oxygen or light penetration, the team aims to improve patient outcomes significantly. Their innovative approach utilizes unique properties of inorganic nanoparticles to enhance therapeutic results, especially in difficult-to-treat conditions.

Dr. Steve Bin Jiang's lab focuses on improving cancer treatment through advanced technologies in radiotherapy. They are developing an Artificial Intelligence-based system to enhance quality assurance for a new type of radiotherapy known as MR-LINAC, which combines radiation treatment with MRI imaging. This innovative approach aims to ensure that cancer treatments are safer and more personalized by accurately adapting to changes in a patient's anatomy over time.

Todd A. Aguilera's lab at UT Southwestern Medical Center focuses on improving treatment outcomes for rectal cancer through innovative approaches combining radiation therapy and immunotherapy. By analyzing patient biopsy tissues before and after treatment, the lab aims to understand the cellular and molecular responses to therapy, which can lead to personalized treatment strategies. The lab is involved in clinical trials exploring new therapies that could potentially allow patients to avoid surgery while effectively managing their cancer.

Dr. Prasanna G Alluri's lab focuses on understanding and overcoming treatment resistance in breast cancer, specifically through targeting two proteins called CDK4 and CDK6. The team is investigating how these proteins contribute to tumor growth and resistance to therapies, aiming to develop new strategies to improve treatment outcomes for patients with estrogen receptor-positive breast cancer. Their research combines advanced genomic and machine learning techniques to explore how modifying the expression of CDK6 can help combat drug resistance in cancer cells.

Dr. David Winland Sanders' lab at UT Southwestern focuses on understanding how RNA-rich structures in cells, known as biomolecular condensates, influence RNA homeostasis and their roles in diseases like ALS. By exploring the dynamics of these membraneless compartments, the lab aims to uncover the mechanisms behind neuromuscular diseases caused by protein aggregates. The research combines insights from biophysics and cell biology to identify potential therapeutic targets for treatment.

Dr. Spencer L. Bowen's lab focuses on advancing imaging techniques for heart diseases, specifically using combined PET and MRI technology. The team is developing innovative methods to improve the accuracy of PET images during cardiac exams, particularly for conditions like cardiac sarcoidosis. Their work aims to reduce patient wait times and enhance the quality of diagnostic imaging, helping to provide better outcomes for patients with complex heart conditions.

Dr. James S. Malter's lab focuses on understanding how calcium signaling affects neuron health in Alzheimer's disease. The team is studying the entorhinal cortex and hippocampus to identify mechanisms that contribute to memory deficits. By investigating specific proteins involved in calcium regulation, they aim to find potential treatments to improve cognitive function in early stages of Alzheimer's disease.

Dr. Andrew Zhuang Wang's lab at UT Southwestern Medical Center focuses on creating advanced models to study how cancer spreads, particularly to specific organs. By engineering tissues that mimic these organs, they aim to understand the factors that influence metastasis and improve cancer treatment strategies. The lab's innovative approach combines biology and engineering to develop tools that could lead to breakthroughs in precision medicine for cancer patients.

Boyuan Wang's research lab at UT Southwestern Medical Center explores how bacteria communicate and respond to stress through a molecule called (p)ppGpp. This molecule helps bacteria survive antibiotics by halting their growth. The lab focuses on understanding the role of enzymes that degrade (p)ppGpp and how metal stress from the human body affects these enzymes. The ultimate goal is to discover new treatment methods to combat persistent bacterial infections.

Dr. Qing Zhang's lab at UT Southwestern Medical Center focuses on understanding clear cell renal cell carcinoma (ccRCC), a highly aggressive form of kidney cancer that often metastasizes to the lungs. The lab uses advanced techniques like CRISPR screening and RNA sequencing to uncover the molecular mechanisms behind this cancer's progression and treatment resistance. Their research aims to identify new therapeutic targets that could improve survival outcomes for patients with metastatic kidney cancer.

Dr. John David Farrar's lab at UT Southwestern Medical Center studies how the body's internal clocks, known as circadian rhythms, affect immune responses, particularly in T cells responding to influenza. The lab investigates the role of specific receptors that communicate signals from the nervous system to immune cells, aiming to better understand how timing influences the effectiveness of immunity. This research could lead to advancements in vaccine design and improve our insights into how time-related factors such as jet lag affect immune function during viral infections.

Carla B. Green's lab focuses on understanding how the body's internal clocks regulate metabolism and contribute to health. They study a protein called Nocturnin, which plays a key role in processing certain molecules that influence metabolic functions. By examining specific gene functions in mice, they hope to uncover how disruptions in circadian rhythms can lead to obesity and other metabolic diseases, aiming to find potential treatments for related health issues.

Dr. Kan Ding's lab focuses on understanding the effects of traumatic brain injury (TBI) on cognitive function and its relationship with cerebrovascular health. They investigate how early cerebrovascular dysfunction after TBI impacts cognitive recovery and the risk of long-term neurodegenerative conditions like Alzheimer's disease. Through longitudinal studies, they aim to identify mechanisms to improve cognitive outcomes for TBI survivors.

Dr. David R. Corey’s lab focuses on understanding how nucleic acids interact with cells to regulate gene expression. The research aims to develop nucleic acid-based therapies for diseases, exploring mechanisms of RNA-mediated recognition, particularly in the cell nucleus. The lab's work has the potential to lead to innovative treatments for genetic disorders by manipulating gene expression at the molecular level.

Dr. Ivan D'Orso's lab focuses on understanding how the HIV-1 virus remains hidden in the body and how it can be reactivated. They explore the role of transcription factors and viral enhancers in regulating HIV-1's activation, which could lead to new treatments or cures for HIV infections. By studying cellular models and samples from infected patients, the lab aims to reveal the mechanisms that control HIV's behavior in latent states, contributing to the global effort to end the HIV epidemic.

Dr. Marc I. Diamond's lab at UT Southwestern focuses on understanding how tau proteins contribute to neurodegenerative diseases like Alzheimer's. They explore how tau protein aggregates spread between brain cells and how these aggregates can enter cells, which might help in developing new therapeutic strategies. The lab combines mechanisms of protein binding and cellular uptake in their research to unravel the complexities of tau-related pathology.

Dr. Elan D. Louis's lab focuses on exploring essential tremor (ET), a common neurological condition that affects millions of Americans. The lab is investigating the use of PET imaging to measure a potential biomarker, synaptic vesicle glycoprotein 2A (SV2A), which may help diagnose ET and track its progression, a crucial development given the lack of current biomarkers for this disease. Their research not only aims to enhance diagnostic accuracy but also aims to differentiate ET from related movement disorders.

Dr. Jennifer Kohler's lab at UT Southwestern Medical Center studies glycoconjugates, which are complex sugar molecules found on cell surfaces. They explore how these molecules interact with pathogens like cholera toxin and how they vary from person to person, potentially influencing diseases and infection vulnerability. The lab develops innovative chemical biology tools to investigate these questions, helping to further our understanding of cell biology and disease processes.

Dr. Ihab M. Hajjar's research lab at UT Southwestern Medical Center focuses on understanding how COVID-19 affects the brain, especially in older African Americans. They investigate long-term cognitive issues that some people face after recovering from the virus, examining factors like age, health conditions, and brain imaging. The goal is to better identify those at risk and improve healthcare outcomes for vulnerable populations.

Dr. Mike Henne's lab focuses on understanding how our bodies store and utilize fats, specifically through tiny organelles called lipid droplets. The research primarily explores how different organs like the liver and kidneys balance lipid storage and signaling, which is crucial for maintaining health and preventing diseases such as fatty liver disease and type 2 diabetes. By using genetic tools in fruit flies and mice, the lab investigates the pathways that regulate these processes, aiming to uncover new ways to treat metabolic disorders.